title: Chimeric antigen receptor-engineered primary natural killer cells: a tool to improve adoptive tumor immunotherapy.
authors.affiliation: Department of Neurosurgery, Section Experimental Neurosurgery & Tumor Immunology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307 Dresden, Germany.|German Cancer Consortium (DKTK), Dresden, Germany, & German Cancer Research Center (DKFZ), Heidelberg, Germany.
authors.forename: Achim
authors.initials: A
authors.lastname: Temme
authors.affiliation: Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Germany; National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany.|German Cancer Consortium (DKTK), Dresden, Germany, & German Cancer Research Center (DKFZ), Heidelberg, Germany.
authors.forename: Marc
authors.initials: M
authors.lastname: Schmitz
mesh_terms: D000818:Animals; D003131:Combined Modality Therapy; D003602:Cytotoxicity, Immunologic; D005818:Genetic Engineering; D015316:Genetic Therapy; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007694:Killer Cells, Natural / Q000502:physiology*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011946:Receptors, Antigen / Q000235:genetics*; D011993:Recombinant Fusion Proteins / Q000235:genetics*
chemical_list: D011946:Receptors, Antigen; D011993:Recombinant Fusion Proteins
keywords: chimeric antigen receptor; genetic engineering; primary natural killer cells; tumor immunotherapy